乙醇酸
单体
乳酸
化学工程
纳米颗粒
化学
纳米技术
材料科学
聚合物
生物
细菌
工程类
有机化学
遗传学
作者
Bocui Song,Qian Chen,Chunyu Tong,Yuqi Li,S. Li,Xue Shen,Wenqi Niu,Meihan Hao,Yunfei Ma,Yanhong Wang
出处
期刊:Current Drug Delivery
[Bentham Science]
日期:2023-10-11
卷期号:21 (8): 1050-1061
标识
DOI:10.2174/0115672018255493230922101434
摘要
Immunomodulatory mechanisms are indispensable and key factors in maintaining the balance of the environment in humans. When the immune function of the immune system is impaired, autoimmune diseases occur. Excessive body fatigue, natural aging of the human body, malnutrition, genetic factors and other reasons cause low immune function, due to which the body is prone to being infected by bacteria or cancer. Clinically, the existing therapeutic drugs still have problems such as high toxicity, long treatment cycle, drug resistance and high price, so we still need to explore and develop a high efficiency and low toxicity drug. Poly(lactic-co-glycolic acid) (PLGA) refers to a nontoxic polymer compound that exhibits excellent biocompatibility. Traditional Chinese medicine (TCM) monomers come from natural plants, and have the characteristics of high efficiency and low toxicity. Applying PLGA to TCM monomers can make up for the defects of traditional dosage forms, improve bioavailability, reduce the frequency and dosage of drug use, and reduce toxicity and side effects, thus having the characteristics of sustained release and targeting. Accordingly, PLGA nanoparticles loaded with TCM monomers have been the focus of development. The previous research on drug loading advantages, preparation methods, and immune regulation of TCM PLGA nanoparticles is summarized in the following sections.
科研通智能强力驱动
Strongly Powered by AbleSci AI